Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

FDA prioritizes review of enfortumab vedotin and pembrolizumab for muscle-invasive bladder cancer, showing promising results in reducing recurrence and mortality.

Results from the pivotal EV-303 trial demonstrated that, when used before and after surgery, the combination reduced the risk of recurrence, progression or death by 60% and the risk of death by 50% in ...

Nirogacestat significantly improved progression-free survival and objective response rates in desmoid tumor patients compared ...

Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...

Learn how lessons from medical robot design can be applied to all robotics from cobots to humanoids and autonomous mobile ...

Whether it is an unexplained change of sensation in the feet or a penchant for not wearing shoes, this is a list of red flags ...

Experts continue to debate whether the health status benefits are real and enough to justify doing the procedures for severe ...

In the past, the Pitt/UPMC team has used thalamus-targeting DBS to restore arm mobility in patients with partial paralysis due to traumatic brain injury and stroke. Researchers think that this precise ...